Trials / Completed
CompletedNCT04830371
Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants
A Phase II/III, Multicenter, Observer-Blinded, Randomized, Non-inferiority and Safety Study of Typhoid Conjugate Vaccine (EuTCV) Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 444 (actual)
- Sponsor
- EuBiologics Co.,Ltd · Industry
- Sex
- All
- Age
- 6 Months – 45 Years
- Healthy volunteers
- Accepted
Summary
This is an observer-blinded, comparative, single dose, clinical phase II/III study to assess the immunogenicity and safety of EuTCV compared to Typhoid conjugate vaccine in healthy Filipino participants aged 6 months to 45 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | EuTCV (Vi-CRM Typhoid conjugate vaccine) | Single dose, Intramuscular administration |
| BIOLOGICAL | Typbar-TCV | Single dose, Intramuscular administration |
Timeline
- Start date
- 2020-09-07
- Primary completion
- 2021-03-18
- Completion
- 2021-08-01
- First posted
- 2021-04-05
- Last updated
- 2021-10-07
Locations
2 sites across 1 country: Philippines
Source: ClinicalTrials.gov record NCT04830371. Inclusion in this directory is not an endorsement.